Latest Shareholder Rights News

Mayne Pharma has announced the rescheduling of its Supreme Court hearing to November 3, 2025, to approve the acquisition scheme by Cosette Australia BidCo, pending Foreign Investment Review Board approval.

Alligator Energy Limited has released its comprehensive company constitution, detailing governance, shareholder rights, and director responsibilities under Australian law and ASX rules. This foundational document sets the framework for the company’s operations and compliance.

Emu NL has agreed to delay issuing shortfall securities tied to its recent entitlement offer until late October, as the Takeovers Panel continues its review following a challenge by Dronkay Pty Ltd.

Turners Automotive Group Limited has announced a fully franked ordinary dividend for the quarter ending June 2025, accompanied by a dividend reinvestment plan offering a 2% discount.

Cobram Estate Olives has successfully closed a $6.1 million Share Purchase Plan alongside a $2 million shortfall placement, fueling its US growth ambitions. The capital raise complements a recent $175 million institutional placement, underpinning the company’s strategic farmland acquisitions and olive grove developments in America.

Rewardle Holdings will be removed from the ASX Official List on 3 October 2025 due to non-compliance with key listing rules, but plans to continue operations as an unlisted company while exploring a move to the NSX.

Eagers Automotive Limited is set to acquire a controlling 65% interest in CanadaOne Auto Group in a transaction valued at C$2.145 billion, with closing anticipated in early 2026.

Iluka Resources has updated its dividend details for the first half of 2025, confirming a fully franked dividend of 2 cents per share and announcing a Dividend Reinvestment Plan price of AUD 6.0274.

The Fair Competition Commission of Tanzania has approved Shenghe Resources’ acquisition of Peak Rare Earths, clearing a major regulatory hurdle for the deal. The scheme now awaits Australian court approval and independent expert endorsement.

Peak Rare Earths has postponed its critical court hearing for Shenghe Resources' acquisition scheme due to a delay in Tanzanian regulatory approval, pushing the decision to 19 September 2025.

EMVision Medical Devices has raised $12 million through a placement backed by institutional investors, including strategic partner Keysight Technologies, and launched a Share Purchase Plan to raise up to $2 million from existing shareholders. The capital will support key clinical and regulatory milestones for its neurodiagnostic devices over the next two years.

SkyCity Entertainment Group has successfully completed a NZ$240 million equity raise through a fully underwritten entitlement offer, with retail shareholders subscribing to one-third of their entitlements. New shares will begin trading next week on both the NZX and ASX.